← All trials

NCT05352347

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Apr 12, 2022
Primary completion
Sep 30, 2022
Completion date
Dec 31, 2022
First posted
Apr 28, 2022
Last posted
Apr 28, 2022
Enrollment
1134
Arms / groups
3 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.